Answers are grounded in this paper and cite their sources.
Multicenter cohort study demonstrates accurate prediction of early hip arthroplasty conversion using multimodal CT and clinical data, highlighting potential for personalized surgical planning.
Intracapsular hip fractures are a leading cause of disability in young and middle-aged adults and are associated with high failure and reoperation rates. Accurate preoperative prediction of conversion to arthroplasty is crucial for quantifying individual prognosis and potentially informing individualized, clinician-led treatment decisions. Yet models built solely on structured electronic health records (EHRs) are insufficient. Here, we introduce MMHIP, trained on a four-center development cohort ( n = 951) and externally tested in three independent centers ( n = 240). To our knowledge, this is the largest multi-center cohort integrating 3D CT and long-term follow-up scans for this task. Advancing beyond conventional approaches, MMHIP integrates preoperative pelvic CT with EHR data, achieving AUROC 0.920 in development and 0.873 on external validation, significantly outperforming representative image-only and EHR-only baselines ( p < 0.05). Incorporating CT markedly improved discrimination over EHR-based models, with absolute AUROC gains of 0.150–0.252 in development and 0.151–0.221 externally. Using a development-derived PPV-targeted operating threshold, MMHIP stratified patients into lower- and higher-predicted conversion-risk groups. At this threshold, MMHIP achieved a PPV of 0.901, sensitivity of 0.654, specificity of 0.980, and NPV of 0.910 in the development set; when applied unchanged to the external testing set, it maintained a PPV of 0.900, sensitivity of 0.529, specificity of 0.984, and NPV of 0.886, outperforming the single-modal comparators in threshold-based risk stratification. These findings support MMHIP as an interpretable preoperative risk-stratification model that may provide clinically relevant prognostic information for individualized, clinician-led treatment decisions.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: